Search

MONORESISTANCE GENES AS MARKERS IN PERSONALIZED THERAPY FOR LUNG CANCER

Tsyganov M.M., Deryusheva I.V., Rodionov E.O., Ibragimova M.K., Miller S.V., Litviakov N.V.

Surgery results of the treatment of the stage II–III lung cancer remains to be unsatisfactory, and used the chemotherapy fails to improve the survival. The main obstacle is the use of standard clinical parameters for the treatment strategy and not enough effec…